Status:
UNKNOWN
Substudy : Patients With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Lead Sponsor:
Laval University
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
50-75 years
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Its prevalence is in progression and COPD is expected to become the fourth leading cause of death ...
Detailed Description
Focusing our attention during exacerbations, a period of aggravated systemic inflammation, should be more rewarding in terms of understanding the link between inflammation burst and muscle disease in ...
Eligibility Criteria
Inclusion
- male and female
- COPD with an FEV1 of under 60% of predicted
- non-smoker
- between 50 and 75 years old
- experiencing an acute exacerbation of COPD (24-48 hours, before treatment)
Exclusion
- all inflammatory disease (HIV, cancer, renal and cardiac deficiency)
- hormonal dysregulation
- inferior limb pathology
- neuromuscular pathology
- history of tobacco or alcool abuse
- oxygen dependent
Key Trial Info
Start Date :
May 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02282436
Start Date
May 1 2012
End Date
May 1 2018
Last Update
September 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de recherche de l'Institut de cardiologie et de pneumologie de Québec
Québec, Quebec, Canada, G1V 4G5